Clinical Trials Browser

Phase EARLY_PHASE1 × Terminated × Multiple Myeloma × Clear all

NCT03804424 2024-11-12

64Cu-LLP2A for Imaging Multiple Myeloma

Phase EARLY_PHASE1 Terminated

Multiple Myeloma

NCT03272633 2023-06-26

Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies

Phase EARLY_PHASE1 Terminated

2 enrolled 6 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Chromosome 17 deletion, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03173430 2020-02-07

Pilot Study of Blinatumomab in Combination With Salvage Autologous Stem Cell Transplantation for Patients With Refractory Multiple Myeloma

Phase EARLY_PHASE1 Terminated

Multiple Myeloma

NCT00470093 2018-11-16

Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma

Phase EARLY_PHASE1 Terminated

3 enrolled 6 charts

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01537861 2015-01-26

Filgrastim in Treating Patients With Bortezomib-, Carfilzomib-, or IMID-Refractory Multiple Myeloma

Phase EARLY_PHASE1 Terminated

Multiple Myeloma